Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor VIII preparations

M Wickerhauser

    The New England Journal of Medicine
    |April 26, 1973
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Large-scale preparation of a highly purified solvent-detergent treated factor VIII concentrate.

    Vox sanguinis·1991
    Same author

    Heat stability of lyophilized C1 inactivator concentrates.

    Vox sanguinis·1987
    Same author

    Pasteurization of C1 inactivator in the presence of citrate salts.

    Vox sanguinis·1984
    Same author

    A single-step method for the isolation of antithrombin III.

    Vox sanguinis·1984
    Same author

    A simplified method for the preparation of immune-serum globulin.

    Vox sanguinis·1981
    Same author

    Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor.

    The New England journal of medicine·1980
    Same journal

    Advances in Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

    The New England journal of medicine·2026
    Same journal

    Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

    The New England journal of medicine·2026
    See all related articles